Gsa Capital Partners LLP Emergent Bio Solutions Inc. Transaction History

Gsa Capital Partners LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $184,723 - $360,209	16,793 New	16,793 $198,000
Q1 2022 May 11, 2022	SELL	$36.48 - $52.22 $207,242 - $296,661	-5,681 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $188,097 - $312,511	5,681 New	5,681 $247,000
Q2 2019 Aug 06, 2019	SELL	$39.92 - $53.86 $865,066 - $1.17 Million	-21,670 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $691,377 - $948,403	-14,335 Reduced 39.81%	21,670 $1.1 Million
Q4 2018 Feb 12, 2019	BUY	$55.63 - $73.24 $433,914 - $571,272	7,800 Added 27.65%	36,005 $2.13 Million
Q3 2018 Nov 13, 2018	SELL	$52.05 - $66.51 $2.22 Million - $2.83 Million	-42,594 Reduced 60.16%	28,205 $1.86 Million
Q2 2018 Aug 09, 2018	SELL	$48.33 - $55.64 $1.58 Million - $1.82 Million	-32,700 Reduced 31.59%	70,799 $3.58 Million
Q1 2018 May 11, 2018	BUY	$44.44 - $54.39 $933,240 - $1.14 Million	21,000 Added 25.45%	103,499 $5.45 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $2.59 Million - $3.28 Million	68,699 Added 497.82%	82,499 $3.83 Million
Q3 2017 Nov 20, 2017	BUY	$34.14 - $40.45 $471,132 - $558,210	13,800	13,800 $558,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $427M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.